Profil de l'entreprise

Vous venez de lire:

Resverlogix Establishes Clinical & Scientific Advisory Board to Support the Clinical Development of RVX-208 and Other Bromodomain Inhibitors in Neurodegenerative Diseases

Nouvelles fournies par

Resverlogix Corp.

Jul 16, 2012, 07:30 ET